What is HOPE?

  • First nationwide large-scale pragmatic four-arm (1:1:1:1) parallel cluster randomised control trial with General Practitioners in Singapore
  • Study aim: To evaluate the effectiveness of three combinations of interventions in reducing the risk of cardiovascular disease (CVD) of individuals at risk of CVD in the primary care setting in Singapore
  • Study duration: 6 months per participant
  • Target number of participants: 1,500
  • For information on the research study, click here